Ibrahim Krenawi¹*, Victor Hugo Post², Markus Müller³ and Mohamed Mustafa⁴

¹Consultant Neurologist, Burjeel Royal Hospital, Al Ain, UAE
²Senior Consultant Psychiatrist & Psychotherapist , LVR-Klinik, Bedburg-Hau, Germany
³Resident Physician in Psychiatry, Klinikum Hersfeld-Rotenburg, Germany
⁴Specialist Psychiatrist & Psychotherapist, Praxis CityNord for Psychiatry und Psychotherapy, Dortmund, Germany

*Corresponding Author: Ibrahim Krenawi, Department of Neurology, Burjeel Royal Hospital, Al Ain, UAE.

Received: July 14, 2025; Published: July 21, 2025

Abstract

The problem of post-stroke depression (PSD) is critical and widespread, as some stroke survivors often delay rehabilitation and experience a decreased quality of life. This review discusses the underlying causes, risk factors, symptoms, diagnostic plans, treatment plans, and lifestyle interventions for PSD. The disorder is a complex interplay of neurological injury, emotional stress, and social isolation following a stroke.
Some of the most typical symptoms and manifestations include persistent depressive affect, fatigue, diminished interest in activities, alteration of appetite, and cognitive problems, which are often confused with the overall impact of stroke recovery. Diagnosis is achieved mainly through clinical interviewing, standardized screening instruments, and medical examination in order to eliminate other disorders. Treatment options include antidepressant drugs, psychotherapy, sociability, exercise, and alternative methods such as mindfulness. Other considerations in the management of PSD include lifestyle changes, which can take the form of physical activity, a healthy diet, and emotional support. Early interaction, constant observation, and the participation of caregivers are key to enhancing outcomes. PSD is manageable with a comprehensive care plan, even though it cannot be prevented. To ensure that physical health and emotional status are in a better condition, this review focuses on the necessity of identifying and treating depression as a means of improving stroke recovery.

Keywords: Post-Stroke; Depression; Guide; Recovery

References

1. Guo J., et al. “The advances of post-stroke depression: 2021 update”. Journal of Neurology 3 (2021): 1236-1249.
2. Ore ML and Foli KJ. “Reintegration for post-treatment cancer survivors: A concept analysis”. Journal of Holistic Nursing3 (219): 300-317.
3. Regen F and Benkert O. „Antidepressiva. In: Benkert O, Hippius H. (Hrsg) Kompendium der Psychiatrischen Pharmakotherapie,. . Auflage, Springer; Berlin (2019): S1-208.
4. Ayerbe L., et al. “Explanatory factors for the increased mortality of stroke patients with depression”. Neurology 83 (2014): 2007-2012.
5. Robinson RG. “Post stroke depression: a review”. The American Journal of Psychiatry 73 (2016): 221-231.
6. Pan A., et al. “Depression and the risk of stroke morbidity and mortality: a meta-analysis and systematic review”. JAMA 306 (2011): 1241-1249.
7. Kapfhammer HP. “Psychische Störungen bei somatischen Krankheiten. in:. Möller HJ, Laux G, Kapfhammer HP. “(Hrsg) Psychiatrie Psychosomatik Psychotherapie. 5. Auflage Springer-Verlag; Berlin (2017): 2693-2805.
8. Robinson RG., et al. “Poststroke depression: a review”. The Canadian Journal of Psychiatry 55 (2010): 141-149.
9. Zhou J., et al. “Post-stroke neuropsychiatric complications: Types, pathogenesis, and therapeutic intervention”. Aging and Disease6 (2023): 2127.
10. Aldrich M. “Employability skills: Economics dissertation at University of East Anglia [Preprint] (2019).
11. Frank D., et al. “Pathophysiology and current drug treatments for post-stroke depression: A Review”. International Journal of Molecular Sciences23 (2022): 15114.
12. De Fruyt J., et al. “Anhedonia in depressive disorder: A narrative review”. Psychopathology5-6 (2020): 274-281.
13. Komsiyska D. “Symptoms of post-stroke depression”. Trakia Journal of Sciences3 (2019): 235-242.
14. Suksatan W., et al. “Burdens among familial caregivers of stroke survivors: A literature review”. Working with Older People1 (2021): 37-43.
15. Lee D. “Winslow, the anatomy of suicide”. The History of Suicide in England 1650-1850 (2021): 167-359.
16. Bilek AJ and Richardson D. “Post-stroke delirium and challenges for the rehabilitation setting: A narrative review”. Journal of Stroke and Cerebrovascular Diseases8 (2023): 107149.
17. Lanctôt KL., et al. “Canadian stroke best practice recommendations: Mood, cognition and fatigue following stroke, 6th edition update 2019”. International Journal of Stroke6 (2019): 668-688.
18. Abuhadra BD., et al. “The prevalence of post-traumatic stress disorder, depression, and anxiety in Libya: A systematic review”. Middle East Current Psychiatry1 (2023).
19. Huang F., et al. “Is geriatric depression scale a valid instrument to screen depression in Chinese community-dwelling elderly?” BMC Geriatrics1 (2021).
20. Tay J., et al. “Apathy after stroke: Diagnosis, mechanisms, consequences, and treatment”. International Journal of Stroke5 (2021): 510-518.
21. Lanctot KL., et al. “Canadian stroke best practice recommodations: mood, cognition and fatigue following stroke, 6th edition update 2019”. International Journal of Stroke 15 (2020): 688-688.
22. Chen Y., et al. “Treatment effects of antidepressants in patients with post stroke depression: a meta analysis”. Annals of Pharmacotherapy 40 (2006): 2115-2122.
23. Starkstein SE and Hayhow BD. “Treatment of post-stroke depression”. Current Treatment Options in Neurology 07 (2019): 31.
24. Mortensen JK and Andersen G. “Pharmacological management of post-stroke depression: an update of the evidence and clinical guidance”. Expert Opinion on Pharmacotherapy (2021): 1-10.
25. Deng L., et al. “Efficacy and tolerability of pharmacotherapy for post stroke depression: a network meta analysis”. Oncotarget 9 (2018): 23718-23728.
26. Chen Y., et al. “Antidepressant prophylaxis for post stroke depression: a meta analysis In”. Journal of Clinical Psychopharmacology 22 (2007): 159-166.
27. Chollet F., et al. “Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial”. Lancet Neurology 10 (2011): 123-130.
28. Mead GE., et al. “Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery”. Cochrane Database of Systematic Reviews 11 (2018).
29. Flaster M., et al. “Poststroke depression: a review emphasizing the role of prophylactic treatment and synergy with treatment for motor recovery”. Topics in Stroke Rehabilitation 20 (2013): 139-150.
30. Cholett F., et al. “Use of antidepresant medications to improve outcomes after stroke”. Current Neurology and Neuroscience Reports 13 (2013):
31. Kraglund KL., et al. “Neuroregeneration and vascular protection by citalopram in acute ischemic stroke (TALOS)”. Stroke 49 (2018): 2568-2576.
32. FOCUS trial Collaboration. Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind randomised, controlled trial”. Lancet 393 (2019): 265-274.
33. Legg LA., et al. “Selective serotonin reuptake inhibitors for stroke recovery”. Cochrane Database of Systematic Reviews (2019): 1 CD 009286.
34. Wijeratne T., et al. “A narrative review on the non-pharmacologic interventions in post-stroke depression”. Psychology Research and Behavior Management 15 (2022): 1689-1706.
35. Costello H., et al. “Antidepressant medications in dementia: Evidence and potential mechanisms of treatment-resistance”. Psychological Medicine3 (2023): 654-667.
36. Zhang S., et al. “Neuropsychiatric issues after stroke: Clinical significance and therapeutic implications”. World Journal of Psychiatry6 (2020): 125-138.
37. Curran J. “Cognitive behavioural therapy for dummies Rob Willson rhena branch cognitive behavioural therapy for dummies john wiley and sons first 334 £14.99 0470018380 0470018380”. Mental Health Practice9 (2006): 26-26.
38. Constantin ET and Fonseca S. “The effect of food on mental health”. Revista Internacional de Educação, Saúde e Ambiente2 (2020): 1-17.
39. Izaham A. “Ethical guidelines for Nutritional Management of stroke”. Nutritional Neurosciences (2024): 319-333.
40. BARIŞ EREN N. “A stress management tool in nurses: Mindfulness- based stress reduction”. Black Sea Journal of Health Science3 (2023): 508-510.
41. He C., et al. “Healthy Lifestyles and Post-Stroke Depression: A NHANES-based cross-sectional study of stroke survivors (2025).
42. Moosavi-Movahedi F and Yousefi R. “Good sleep as an important pillar for a healthy life”. University of Tehran Science and Humanities Series (2021): 167-195.
43. Sanson M., et al. “Trigger warnings are trivially helpful at reducing negative affect, intrusive thoughts, and avoidance”. Clinical Psychological Science 4 (2019): 778-793.
44. Enos G. “Mental Health‐Focused Foundation contributes to suicide prevention plan”. Mental Health Weekly25 (2022): 1-7.
45. Bucur M Papagno CA. “Systematic review of noninvasive brain stimulation for post stroke depression”. Journal of Affective Disorders 238 (2018): 69-78.

Citation

Citation: Ibrahim Krenawi., et al. “Understanding and Managing Post-Stroke Depression: A Comprehensive Guide to Recovery".Acta Scientific Neurology 8.8 (2025): 27-38.

Copyright

Copyright: © 2025 Ibrahim Krenawi., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.